Pre-treatment serum protein levels predict survival of non-small cell lung cancer patients without durable clinical benefit by PD-1/L1 inhibitors

Author(s):  
Yuhei Harutani ◽  
Yuichi Ozawa ◽  
Eriko Murakami ◽  
Koichi Sato ◽  
Jun Oyanagi ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document